What happened
Original notice title
Bea Lydecker’s Naturals, Inc. MARCS-CMS 616439, February 09, 2022
From the archived source record
Additionally, your products Adult Extra, Digestion, Nerve & Muscle, Nerve & Muscle Plus Cetyl-Myristoleate, Artho Flex, Enzymes Plus, Immune, Heart / Blood Vessel, Liver / Gall Bladder, Lung & Joint Congestion are misbranded within the meaning of section 403 of the Act [21 U.S.C. § 343]. Unapproved New and Misbranded Drugs During the inspection, we collected labels and labeling related to your dietary supplements, including your Bea Lydecker’s Naturals, Inc. The other problem could be coming from Mercury that has settled in the joints from Dental amalgams or from medications, thus we recommend the Zeolite to clear heavy metals while treating arthritis. The other problem could be coming from Mercury that has settled in the joints from Dental amalgams or from medications, thus we recommend the Zeolite to clear heavy metals while treating arthritis. The volatile oil of the bulb has strong bactericidal action … It has been used to treat liver, gall bladder and intestinal problems, infections, blood pressure and circulation disorders as well as giardia, staphylococcus, streptococcus, and salmonella bacteria and is effective against bacteria resistant to antibiotic drugs.” From the product catalog on your website, www.bealydecker.com: On pages 3 – 4: “I knew something was definitely wrong, but it was not until the tumors filled my lungs, stomach and covered my head, did we get the diagnosis through a biopsy. This product is vital for Alzheimer patients as it helps remove the aluminum and mercury affecting the brain.” From the product catalog on your website, www.bealydecker.com: On page 20 – 21: “LIQUID ZEOLITE: ... A drug is misbranded under section 502(f)(1) of the Act [21 U.S.C. § 352(f)(1)] if the drug fails to bear adequate directions for its intended use(s). Accordingly, your Enzymes Plus, Herbal Extract, Herbal Compound, Heart / Blood Vessel, Immune, Liquid Zeolite, Lung & Joint Congestion, and Magnesium products fail to bear adequate directions for their intended use and, therefore, the products are misbranded under section 502(f)(1) of the Act [21 U.S.C. § 352(f)(1)].
What the official notice says to do
Check the original notice for the instructions that apply to the named product, company, and affected lots.
Read the official notice →Status and source details
- Status recorded in the archive
- No closeout listed in FDA table
- Source checked
- Jul 16, 2026
- Record revision
- 751c037cab7e
This is a dated record. Its current status may have changed since the source was captured. A record applies to its stated scope; it is not a safety rating for every product from a company.
Sources, dates, and coverage →